Sandi L Pruitt1, Jan M Eberth2, E Scott Morris3, David B Grinsfelder4, Erica L Cuate4. 1. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX U.S.A; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX U.S.A. 2. Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC U.S.A; Cancer Prevention and Control Program, University of South Carolina, Columbia, SC U.S.A. 3. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX U.S.A; School of Economic, Political, and Policy Sciences, University of Texas Dallas, Dallas TX U.S.A. 4. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX U.S.A.
Abstract
INTRODUCTION: Rural residence is associated with later stage of breast cancer diagnosis in some but not all prior studies. The lack of a standardized definition of rural residence may contribute to these mixed findings. We characterize and compare multiple definitions of rural vs. non-rural residence to provide guidance regarding choice of measures and to further elucidate rural disparities in breast cancer stage at diagnosis. METHODS: We used Texas Cancer Registry data of 120,738 female breast cancer patients ≥50 years old diagnosed between 1995-2009. We defined rural vs. non-rural residence using 7 different measures and examined their agreement using Kappa statistics. Measures were defined at various geographic levels: county, ZIP code, census tract, and census block group. Late-stage was defined as regional or distant disease. For each measure, we tested the association of rural residence and late-stage cancer with unadjusted and adjusted logistic regression. Covariates included: age; patient race/ethnicity; diagnosis year; census block group-level mammography capacity; and census tract-level percent poverty, percent Hispanic, and percent Black. RESULTS: We found moderate to high levels of agreement between measures of rural vs. non-rural residence. For 72.9% of all patients, all 7 definitions agreed as to rural vs. non-rural residence. Overall, 6 of 7 definitions demonstrated an adverse association between rural residence and late-stage disease in unadjusted and adjusted models (Adjusted OR Range = 1.09-1.14). DISCUSSION: Our results document a clear rural disadvantage in late-stage breast cancer. We contribute to the heterogeneous literature by comparing varied measures of rural residence. We recommend use of the census tract-level Rural Urban Commuting Area Codes in future cancer outcomes research where small area data are available.
INTRODUCTION: Rural residence is associated with later stage of breast cancer diagnosis in some but not all prior studies. The lack of a standardized definition of rural residence may contribute to these mixed findings. We characterize and compare multiple definitions of rural vs. non-rural residence to provide guidance regarding choice of measures and to further elucidate rural disparities in breast cancer stage at diagnosis. METHODS: We used Texas Cancer Registry data of 120,738 female breast cancerpatients ≥50 years old diagnosed between 1995-2009. We defined rural vs. non-rural residence using 7 different measures and examined their agreement using Kappa statistics. Measures were defined at various geographic levels: county, ZIP code, census tract, and census block group. Late-stage was defined as regional or distant disease. For each measure, we tested the association of rural residence and late-stage cancer with unadjusted and adjusted logistic regression. Covariates included: age; patient race/ethnicity; diagnosis year; census block group-level mammography capacity; and census tract-level percent poverty, percent Hispanic, and percent Black. RESULTS: We found moderate to high levels of agreement between measures of rural vs. non-rural residence. For 72.9% of all patients, all 7 definitions agreed as to rural vs. non-rural residence. Overall, 6 of 7 definitions demonstrated an adverse association between rural residence and late-stage disease in unadjusted and adjusted models (Adjusted OR Range = 1.09-1.14). DISCUSSION: Our results document a clear rural disadvantage in late-stage breast cancer. We contribute to the heterogeneous literature by comparing varied measures of rural residence. We recommend use of the census tract-level Rural Urban Commuting Area Codes in future cancer outcomes research where small area data are available.
Entities:
Keywords:
breast cancer; cancer stage; health disparities; measurement; rural
Authors: Nancy Krieger; Pamela D Waterman; Jarvis T Chen; Mah-Jabeen Soobader; S V Subramanian Journal: Public Health Rep Date: 2003 May-Jun Impact factor: 2.792
Authors: Kevin A Henry; Recinda Sherman; Steve Farber; Myles Cockburn; Daniel W Goldberg; Antoinette M Stroup Journal: Health Place Date: 2013-03-01 Impact factor: 4.078
Authors: Stephanie A Robert; Indiana Strombom; Amy Trentham-Dietz; John M Hampton; Jane A McElroy; Polly A Newcomb; Patrick L Remington Journal: Epidemiology Date: 2004-07 Impact factor: 4.822
Authors: Shawnita Sealy-Jefferson; Molly E Roseland; Michele L Cote; Amy Lehman; Eric A Whitsel; Faheemah N Mustafaa; Jason Booza; Michael S Simon Journal: J Womens Health (Larchmt) Date: 2018-09-27 Impact factor: 2.681
Authors: Yamile Molina; Kristine Zimmermann; Leslie R Carnahan; Ellen Paulsey; Cabral A Bigman; Manorama M Khare; Whitney Zahnd; Wiley D Jenkins Journal: J Cancer Educ Date: 2018-08 Impact factor: 2.037
Authors: Kaitlin M McGrew; Jennifer D Peck; Sara K Vesely; Amanda E Janitz; Cuyler A Snider; Tyler M Dougherty; Janis E Campbell Journal: J Public Health Manag Pract Date: 2019 Sep/Oct
Authors: Whitney E Zahnd; Natalie Del Vecchio; Natoshia Askelson; Jan M Eberth; Robin C Vanderpool; Linda Overholser; Purnima Madhivanan; Rachel Hirschey; Jean Edward Journal: Health Serv Res Date: 2022-03-07 Impact factor: 3.734
Authors: Smita Bhatia; Wendy Landier; Electra D Paskett; Katherine B Peters; Janette K Merrill; Jonathan Phillips; Raymond U Osarogiagbon Journal: J Natl Cancer Inst Date: 2022-07-11 Impact factor: 11.816
Authors: Caitlin C Murphy; Philip J Lupo; Michael E Roth; Naomi J Winick; Sandi L Pruitt Journal: J Natl Cancer Inst Date: 2021-08-02 Impact factor: 13.506
Authors: Kathryn E Weaver; Chandylen L Nightingale; Julia A Lawrence; Jennifer Talton; Sally Hauser; Ann M Geiger Journal: Support Care Cancer Date: 2019-12-13 Impact factor: 3.603
Authors: Hannah Claire Sibold; Mary Catherine Thomson; Rachel Hianik; Eli R Abernethy; Gavin P Campbell; Bradley Sumrall; Melissa Dillmon; Josh Simmons; Jeffrey M Switchenko; Margie D Dixon; Rebecca D Pentz Journal: Cancer Date: 2021-07-21 Impact factor: 6.860